Aghdassi, E., Wendland, B.E., Steinhart, A.H., Wolman, S.L., Jeejeebhoy, K. and Allard, J.P., 2003. Antioxidant vitamin supplementation in Crohn’s disease decreases oxidative stress: a randomized controlled trial. American Journal of Gastroenterology 98: 348-353.
MedlineGoogle Scholar
Al-Harbi, N.O., Imam, F., Nadeem, A., Al-Harbi, M.M., Iqbal, M. and Ahmad, S.F., 2014. Carbon tetrachloride-induced hepatotoxicity in rat is reversed by treatment with riboflavin. International Immunopharmacology 21: 383-388.
Crossref, MedlineGoogle Scholar
Alam, M.M., Iqbal, S. and Naseem, I., 2015. Ameliorative effect of riboflavin on hyperglycemia, oxidative stress and DNA damage in type-2 diabetic mice: mechanistic and therapeutic strategies. Archives of Biochemistry and Biophysics 584: 10-19.
Crossref, MedlineGoogle Scholar
Arena, M.P., Russo, P., Capozzi, V., Rascón, A., Felis, G.E., Spano, G. and Fiocco, D., 2016. Combinations of cereal β-glucans and probiotics can enhance the anti-inflammatory activity on host cells by a synergistic effect. Journal of Functional Foods 23: 12-23.
CrossrefGoogle Scholar
De Moreno de LeBlanc, A., Chaves, S. and Perdigon, G., 2009. Effect of yoghurt on the cytokine profile using a murine model of intestinal inflammation. European Journal of Inflammation 7: 97-109.
CrossrefGoogle Scholar
De Moreno de LeBlanc, A. and LeBlanc, J.G., 2014. Effect of probiotic administration on the intestinal microbiota, current knowledge and potential applications. World Journal of Gastroenterology 20: 16518-16528.
Crossref, MedlineGoogle Scholar
Del Carmen, S., De Moreno de LeBlanc, A., Perdigon, G., Bastos Pereira, V., Miyoshi, A., Azevedo, V. and LeBlanc, J.G., 2011. Evaluation of the anti-inflammatory effect of milk fermented by a strain of IL-10-producing Lactococcus lactis using a murine model of Crohn’s disease. Journal of Molecular Microbiology Biotechnology 21: 138-146.
Crossref, MedlineGoogle Scholar
Del Carmen, S., Miyoshi, A., Azevedo, V., De Moreno de LeBlanc, A. and LeBlanc, J.G., 2015. Evaluation of a Streptococcus thermophilus strain with innate anti-inflammatory properties as a vehicle for IL-10 cDNA delivery in an acute colitis model. Cytokine 73: 177-183.
Crossref, MedlineGoogle Scholar
Del Carmen, S., Zurita-Turk, M., Alvarenga Lima, F., Coelho dos Santos, J.S., Leclercq, S.Y., Chatel, J.-M., Azevedo, V., De Moreno de LeBlanc, A., Miyoshi, A. and LeBlanc, J.G., 2013. A novel interleukin-10 DNA mucosal delivery system attenuates intestinal inflammation in a mouse model. European Journal of Inflammation 11: 641-654.
CrossrefGoogle Scholar
Hlavaty, T., Krajcovicova, A. and Payer, J., 2015. Vitamin D therapy in inflammatory bowel diseases: who, in what form, and how much? Journal of Crohn’s and Colitis 9: 198-209.
Crossref, MedlineGoogle Scholar
Iwanaga, K., Hasegawa, T., Hultquist, D.E., Harada, H., Yoshikawa, Y., Yanamadala, S., Liao, H., Visovatti, S.H. and Pinsky, D.J., 2007. Riboflavin-mediated reduction of oxidant injury, rejection, and vasculopathy after cardiac allotransplantation. Transplantation 83: 747-753.
Crossref, MedlineGoogle Scholar
Juarez del Valle, M., Laiño, J.E., Savoy de Giori, G. and LeBlanc, J.G., 2014. Riboflavin producing lactic acid bacteria as a biotechnological strategy to obtain bio-enriched soymilk. Food Research International 62: 1015-1019.
CrossrefGoogle Scholar
LeBlanc, J.G., Laino, J.E., Juarez del Valle, M., Vannini, V., Van Sinderen, D., Taranto, M.P., Font de Valdez, G., Savoy de Giori, G. and Sesma, F., 2011a. B-group vitamin production by lactic acid bacteria – current knowledge and potential applications. Journal of Applied Microbiology 111: 1297-1309.
Crossref, MedlineGoogle Scholar
LeBlanc, J.G., Del Carmen, S., Miyoshi, A., Azevedo, V., Sesma, F., Langella, P., Bermudez-Humaran, L.G., Watterlot, L., Perdigon, G. and De Moreno de LeBlanc, A., 2011b. Use of superoxide dismutase and catalase producing lactic acid bacteria in TNBS induced Crohn’s disease in mice. Journal of Biotechnology 151: 287-293.
Crossref, MedlineGoogle Scholar
Mazur-Bialy, A.I., Pochec, E. and Plytycz, B., 2015. Immunomodulatory effect of riboflavin deficiency and enrichment-reversible pathological response versus silencing of inflammatory activation. Journal of Physiology and Pharmacology 66: 793-802.
MedlineGoogle Scholar
Meyer, L., Simian, D., Lubascher, J., Acuna, R., Figueroa, C., Silva, G., Brahm, J. and Quera, R., 2015. Adverse events associated with the treatment of inflammatory bowel disease. Revista Médica de Chile 143: 7-13.
MedlineGoogle Scholar
Moura, F.A., De Andrade, K.Q., Dos Santos, J.C., Araujo, O.R. and Goulart, M.O., 2015. Antioxidant therapy for treatment of inflammatory bowel disease: does it work? Redox Biology 6: 617-639.
Crossref, MedlineGoogle Scholar
Powers, H.J., 2003. Riboflavin (vitamin B-2) and health. American Journal of Clinical Nutrition 77: 1352-1360.
Crossref, MedlineGoogle Scholar
Roggenbuck, C., Lammert, F., Berthold, H.K., Giese, T., Stallmach, A., Stehle, P. and Ellinger, S., 2008. High-dose oral supplementation of antioxidants and glutamine improves the antioxidant status in patients with Crohn’s disease: a pilot study. European Journal of Clinical Nutrition and Metabolism 3: e246-e253.
Google Scholar
Russo, P., Capozzi, V., Arena, M.P., Spadaccino, G., Duenas, M.T., Lopez, P., Fiocco, D. and Spano, G., 2014. Riboflavin-overproducing strains of Lactobacillus fermentum for riboflavin-enriched bread. Applied Microbiology and Biotechnology 98: 3691-3700.
Crossref, MedlineGoogle Scholar
Russo, P., De Chiara, M.L.V., Capozzi, V., Arena, M.P., Amodio, M.L., Rascón, A., Dueñas, M.T., López, P. and Spano, G., 2016. Lactobacillus plantarum strains for multifunctional oat-based foods. LWT-Food Science and Technology 68: 288-294.
CrossrefGoogle Scholar
Thakur, K., Tomar, S.K. and De, S., 2015. Lactic acid bacteria as a cell factory for riboflavin production. Microbial Biotechnology 9: 441-451.
Crossref, MedlineGoogle Scholar

New titles

Related titles:

< >

Issue Details

Beneficial Microbes


Beneficial Microbes

Publication Cover
Print ISSN: 1876-2883
Online ISSN: 1876-2891
Get Permission

2022 Journal Impact Factor 5.4
source: Journal Impact Factor 2023™ from Clarivate™

2022 CiteScore

Purchase Options

Institutional Offers

For institutional orders, please contact [email protected].